Should You Buy the Hyperliquid Cryptocurrency or the Stock?

Hyperliquid’s HYPE token is backed by a buyback-and-burn model that absorbs about 97% of trading fees, while the publicly listed Hyperliquid Strategies holds 17.6 million HYPE, $112.6 million in cash, and zero debt as of early 2026. The article argues HYPE offers the most direct exposure, but warns that only 42.5% of the 1 billion token supply is circulating and monthly unlocks of roughly 10 million tokens continue through October 2027, creating dilution risk. The stock provides easier access and a $30 million buyback program, but also carries dilution risk if new shares are issued to buy more tokens.

Analysis

The key market mistake is treating the equity wrapper and the token as interchangeable exposure. They are not: the token is a cleaner claim on protocol cash flow, while the stock is a leveraged, balance-sheet-mediated derivative on that same flow with additional governance and dilution risk. In practice, that means the equity should trade at a persistent discount to the token NAV unless the market starts pricing a sustained ability to accrete per-share HYPE faster than it can be diluted.

The second-order issue is supply overhang, not current usage. With a large portion of supply still locked and periodic unlocks continuing for years, buybacks are only powerful if fee growth compounds faster than emission. That creates a nonlinear setup: if volumes stay hot, the burn mechanism can absorb supply and support reflexive upside; if activity decelerates even modestly, the market is left with a visible unlock calendar and a thinner bid, which can compress the token multiple quickly.

The stock has a different path dependency. Corporate buybacks help at wide discounts to NAV, but the real gating factor is whether management uses equity issuance opportunistically to arbitrage the token price higher, which is structurally dilutive to existing shareholders even if accretive on a gross token basis. That makes the equity more suitable for traders who want regulated brokerage access and can tolerate NAV discount volatility, not for investors seeking the purest expression of protocol success.

Consensus appears to be underestimating how reflexive this can become on the downside as well as the upside. The same mechanism that supports HYPE in a strong fee environment can reverse if perp volumes mean-revert, especially because crypto derivatives activity is highly momentum-driven and sensitive to broader risk appetite. The cleaner trade is to own the operating optionality directly, but only with a strict view that usage growth must outrun unlocks over the next 6-18 months.

Key Decisions for Investors

• Prefer HYPE over PURR for directional exposure; size as a tactical momentum trade, not a core long-term hold, and reassess if fee growth fails to outpace monthly unlocks over the next 2-3 quarters.
• If forced to use the equity wrapper, buy PURR only when it trades at a meaningful discount to implied token NAV and the buyback authorization is actively shrinking the share count; otherwise avoid due to dilution risk.
• Pair trade: long HYPE / short PURR when the stock premium to NAV widens materially, targeting mean reversion as the market reprices dilution and overhead over 1-3 months.
• For more defined risk, use call spreads on HYPE rather than spot; this captures upside from continued volume growth while limiting downside if perp activity normalizes over the next 60-120 days.
• Set a hard risk trigger on HYPE if protocol volumes roll over for two consecutive monthly periods; that would likely mark the point where unlock supply stops being absorbed and the token de-rates fast.